4.5 Article

Ag-doped manganite nanoparticles: New materials for temperature-controlled medical hyperthermia

期刊

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
卷 91A, 期 4, 页码 1048-1055

出版社

WILEY
DOI: 10.1002/jbm.a.32177

关键词

controllable hyperthermia; nanoparticles; adjustable Curie temperature

资金

  1. Human Frontier Society Program [RGP 047/2007]
  2. US National Cancer Institute [R21 CA110010-01]
  3. Russian Foundation for Basic Research [05-02-16371, 07-0301019]

向作者/读者索取更多资源

The purpose Of this Study was to introduce newly synthesized nanomaterials as an alternative to superparamagnetic ironoxide based particles (SPIO) and thus to launch a new platform for highly controllable hyperthermia cancer therapy and imaging. The new material that forms the basis for this article is lanthanum manganite particles with silver ions inserted into the perovskite lattice: La1-xAgxMnO3+delta. Adjusting the silver doping level, it is possible to control the Curie temperature (T-c) in the hyperthermia range of interest (41-44 degrees C). A new class of nanoparticles based on silver-doped manganites La1-xAgxMnO3+delta is Suggested. New nanoparticles are stable, and their properties were not affected by the typical ambient conditions in the living tissue. It is possible to monitor the particle uptake and retention by MRI. When these particles are placed into ail alternating magnetic field, their temperature increases to the definite value near T-c and then remains constant if the magnetic field is maintained. During the hyperthermia procedure, the temperature can be restricted, thereby preventing the necrosis of normal tissue. A new class of nanoparticles based on silver-doped manganites La1-xAgxMnO3+delta was Suggested. Ag-doped perovskite manganites particles clearly demonstrated the effect of adjustable Curie temperature necessary for highly controllable cellular hyperthermia. The magnetic relaxation properties of the particles are comparable with that of SPIO, and so we were able to monitor the particle movement and retention by MRI. Thus, the new material combines the MRI contrast enhancement capability with targeted hyperthermia treatment. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 91A: 1048-1055, 2009

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据